J J Bax

Author PubWeight™ 210.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999 5.21
2 No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol 2001 2.31
3 Concern Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001 2.26
4 Left ventricular hypertrophy screening using a hand-held ultrasound device. Eur Heart J 2002 1.95
5 Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J 2002 1.87
6 Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability. Eur Heart J 2001 1.69
7 Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 2000 1.55
8 Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart 2008 1.55
9 COPD and cancer mortality: the influence of statins. Thorax 2009 1.53
10 Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart 2007 1.53
11 No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum 2009 1.53
12 Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification. Eur J Vasc Endovasc Surg 2009 1.51
13 Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart 2006 1.50
14 Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting. J Nucl Cardiol 1999 1.44
15 Perioperative blood glucose monitoring and control in major vascular surgery patients. Eur J Vasc Endovasc Surg 2009 1.43
16 Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab 2001 1.43
17 Cardiac CT and CT coronary angiography: technology and application. Heart 2008 1.42
18 Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium. J Nucl Cardiol 1999 1.40
19 [Screening of asymptomatic individuals for coronary disease using CT-calcium measurement in the coronary arteries]. Ned Tijdschr Geneeskd 2006 1.40
20 Reprinted article "A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery". Eur J Vasc Endovasc Surg 2011 1.40
21 [Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia]. Ned Tijdschr Geneeskd 2006 1.40
22 [Prophylactic perioperative beta-blockade reduces cardiac morbidity and mortality following non-cardiac surgery in patients at risk]. Ned Tijdschr Geneeskd 2004 1.39
23 Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 2005 1.35
24 A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003 1.35
25 Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001 1.34
26 Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003 1.32
27 EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging 2008 1.29
28 Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur J Echocardiogr 2004 1.25
29 Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med 1998 1.17
30 Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation 1999 1.17
31 Clinical application of CT coronary angiography: state of the art. Heart Lung Circ 2010 1.17
32 Intracardiac pseudotumor caused by mitral annular calcification. Eur J Echocardiogr 2005 1.17
33 Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions. Heart 2003 1.15
34 Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998 1.15
35 Imaging in cardiac resynchronisation therapy. Neth Heart J 2008 1.15
36 Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 2006 1.13
37 Anatomical and functional imaging techniques: basically similar or fundamentally different? Neth Heart J 2007 1.11
38 Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non-invasive evaluation with multi-slice computed tomography. Acute Card Care 2007 1.11
39 Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 2001 1.05
40 Abdominal aortic aneurysm screening using a hand-held ultrasound device. "A pilot study". Eur J Vasc Endovasc Surg 2001 1.05
41 Evaluation of left ventricular function and volumes in patients with ischaemic cardiomyopathy: gated single-photon emission computed tomography versus two-dimensional echocardiography. Eur J Nucl Med 2001 1.01
42 Assessment of myocardial viability in chronic ischemic heart disease: current status. Q J Nucl Med Mol Imaging 2005 1.01
43 Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2007 1.01
44 A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2004 1.00
45 The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg 2007 0.99
46 Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med 2008 0.99
47 Echocardiographic evaluation of cardiac dyssynchrony for predicting a favourable response to cardiac resynchronisation therapy. Heart 2004 0.98
48 [Perioperative risk reduction in vascular surgery via cardio-protective medication]. Ned Tijdschr Geneeskd 2008 0.97
49 Cardiac imaging in coronary artery disease: differing modalities. Heart 2005 0.97
50 Technological advances in tissue Doppler imaging echocardiography. Heart 2008 0.97
51 Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood. Heart 2009 0.96
52 Multi-slice computed tomography in the evaluation of patients with acute chest pain. Acute Card Care 2007 0.96
53 Prognostic value of echocardiography after acute myocardial infarction. Heart 2009 0.96
54 Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with (201)Thallium-SPECT and coronary angiography. J Magn Reson Imaging 2000 0.95
55 Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol (Oxf) 2006 0.95
56 Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart 2007 0.94
57 Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur J Vasc Endovasc Surg 2004 0.94
58 Radiofrequency catheter ablation of paroxysmal atrial fibrillation; guidance by intracardiac echocardiography and integration with other imaging techniques. Eur J Echocardiogr 2003 0.93
59 Clinical applications of intracardiac echocardiography in interventional procedures. Heart 2005 0.93
60 Plaque type and composition as evaluated non-invasively by MSCT angiography and invasively by VH IVUS in relation to the degree of stenosis. Heart 2009 0.93
61 Assessment of myocardial viability by dobutamine stress echocardiography. Curr Opin Cardiol 1996 0.93
62 Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 1998 0.92
63 Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2005 0.92
64 CT angiography; no collateral damage. Int J Cardiovasc Imaging 2009 0.91
65 Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registry. Int J Cardiovasc Imaging 2011 0.91
66 Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function. Circ Cardiovasc Imaging 2011 0.91
67 Different value of coronary calcium score to predict obstructive coronary artery disease in patients with and without moderate chronic kidney disease. Neth Heart J 2013 0.91
68 Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT. Heart 2010 0.90
69 Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vasc Endovasc Surg 2006 0.90
70 Comprehensive cardiac assessment with multislice computed tomography: evaluation of left ventricular function and perfusion in addition to coronary anatomy in patients with previous myocardial infarction. Heart 2006 0.90
71 Assessment of left ventricular volumes and ejection fraction with 16-slice multi-slice computed tomography; comparison with 2D-echocardiography. Int J Cardiol 2006 0.90
72 Assessment of myocardial viability: guide to prognosis and clinical management. Eur Heart J 2000 0.89
73 Low blood pressure in the very old, a consequence of imminent heart failure: the Leiden 85-plus Study. J Hum Hypertens 2008 0.89
74 Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med 1998 0.89
75 Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required. Eur J Endocrinol 2008 0.88
76 Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2009 0.88
77 Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 2005 0.87
78 Accuracy of exercise stress technetium 99m sestamibi SPECT imaging in the evaluation of the extent and location of coronary artery disease in patients with an earlier myocardial infarction. J Nucl Cardiol 2001 0.87
79 Prognosis of patients with peripheral arterial disease. J Cardiovasc Surg (Torino) 2009 0.87
80 Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction. Heart 2009 0.87
81 Significance of resting wall motion abnormalities in 2-dimensional echocardiography in patients without previous myocardial infarction referred for pharmacologic stress testing. J Am Soc Echocardiogr 2000 0.86
82 99mTc-MIBI myocardial perfusion imaging in myocarditis. Nucl Med Commun 2003 0.86
83 Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2006 0.86
84 Second harmonic imaging improves sensitivity of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am Heart J 2001 0.86
85 Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction. Heart 2005 0.86
86 Aortic valve regurgitation due to cusp aneurysm: a case report. Eur J Echocardiogr 2004 0.85
87 Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction. Heart 2002 0.85
88 Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction. Am J Cardiol 1998 0.85
89 Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2005 0.85
90 Assessment of left ventricular volumes; reliable by gated SPECT? Int J Cardiovasc Imaging 2010 0.84
91 Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Eur J Vasc Endovasc Surg 2010 0.84
92 Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography. Nucl Med Commun 2003 0.83
93 Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegaly. Eur J Endocrinol 2005 0.83
94 Dobutamine 99Tcm-MIBI SPET myocardial perfusion scintigraphy in the prediction of restenosis after percutaneous transluminal coronary angioplasty in patients unable to perform an exercise stress test. Nucl Med Commun 1997 0.83
95 Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction. Am J Cardiol 1997 0.83
96 Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction. Heart 2001 0.83
97 Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart 2001 0.83
98 Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. Am J Cardiol 2001 0.83
99 Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging 2008 0.83
100 Non-invasive evaluation of left ventricular function by means of impedance cardiography. Acta Anaesthesiol Scand 1999 0.83
101 What is the cause of pulmonary oedema after acute myocardial infarction? A case study. Intensive Care Med 1996 0.83
102 Assessment of regional myocardial wall motion and thickening by gated 99Tcm-tetrofosmin SPECT: a comparison with magnetic resonance imaging. Nucl Med Commun 2001 0.83
103 Coronary artery disease in patients with abdominal aortic aneurysm: a review article. J Cardiovasc Surg (Torino) 2009 0.82
104 Cardiac evaluation in hypotension-prone and hypotension-resistant hemodialysis patients. Kidney Int 1999 0.82
105 Relation between the extent of coronary artery disease and tachyarrhythmias during dobutamine stress echocardiography. Am J Cardiol 1999 0.82
106 Myocardial perfusion abnormalities in treated hypertensive patients without known coronary artery disease. J Hypertens 1999 0.82
107 100 kV versus 120 kV: effective reduction in radiation dose? Int J Cardiovasc Imaging 2010 0.81
108 Echocardiographic follow-up of Chlamydia psittaci myocarditis. Chest 2000 0.81
109 Detection of malignant right coronary artery anomaly by multi-slice CT coronary angiography. Eur Radiol 2002 0.81
110 Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance. Heart 2005 0.81
111 Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly. Chest 2000 0.81
112 Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Endovasc Surg 2007 0.81
113 Optimal criteria for the diagnosis of coronary artery disease by dobutamine stress echocardiography. Am J Cardiol 1998 0.81
114 Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus. Neth J Med 2009 0.81
115 Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. Am J Cardiol 2001 0.81
116 Which stress test is superior for perioperative cardiac risk stratification in patients undergoing major vascular surgery? Eur J Vasc Endovasc Surg 2002 0.81
117 Evaluation of hypertrophic cardiomyopathy: new horizons for CMR? Neth Heart J 2010 0.81
118 Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging. Eur J Nucl Med 1995 0.81
119 Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity. Eur J Echocardiogr 2003 0.81
120 The functional significance of chronotropic incompetence during dobutamine stress test. Heart 1999 0.81
121 Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart 2005 0.81
122 Comparison of dobutamine stress echocardiography and 99m-technetium sestamibi SPECT myocardial perfusion scintigraphy for predicting extent of coronary artery disease in patients with healed myocardial infarction. Am J Cardiol 1997 0.81
123 The prognostic value of impaired walking distance on long-term outcome in patients with known or suspected peripheral arterial disease. Eur J Vasc Endovasc Surg 2009 0.80
124 Cardiac risk and perioperative management. J Cardiovasc Surg (Torino) 2003 0.80
125 Usefulness of pulse-wave Doppler tissue sampling and dobutamine stress echocardiography for the diagnosis of right coronary artery narrowing. Am J Cardiol 1998 0.80
126 Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera. J Nucl Med 1998 0.80
127 Non-invasive anatomical and functional imaging for the detection of coronary artery disease. Br Med Bull 2006 0.80
128 No indication for patent foramen ovale closure in migraine. Neth Heart J 2009 0.80
129 Comparison between serum creatinine and creatinine clearance for the prediction of postoperative mortality in patients undergoing major vascular surgery. Clin Nephrol 2003 0.80
130 Stress imaging in patients with diabetes; routine practice? Int J Cardiovasc Imaging 2010 0.80
131 Does second harmonic imaging improve left ventricular endocardial border identification at higher heart rates during dobutamine stress echocardiography? J Am Soc Echocardiogr 2000 0.80
132 Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT. Chest 1998 0.80
133 Predictive accuracy of echocardiographic response of mildly dyssynergic myocardial segments to low-dose dobutamine. Am J Cardiol 1997 0.79
134 Relation between left ventricular contractile reserve during low dose dobutamine echocardiography and plasma concentrations of natriuretic peptides. Heart 2004 0.79
135 JC virus and multiple sclerosis: a refutation? Acta Neurol Scand 1993 0.79
136 Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction. Am J Cardiol 1999 0.79
137 Measuring left ventricular mechanical dyssynchrony from ECG-gated SPECT myocardial perfusion imaging. Minerva Cardioangiol 2008 0.79
138 320-row CT scanning: reduction in tube current parallels reduction in radiation exposure? Int J Cardiovasc Imaging 2010 0.79
139 The significance of stress-induced ST segment depression in patients with inferior Q wave myocardial infarction. J Am Coll Cardiol 1999 0.78
140 Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation. Heart 2004 0.78
141 Process of care partly explains the variation in mortality between hospitals after peripheral vascular surgery. Eur J Vasc Endovasc Surg 2010 0.78
142 Fingertip digital thermal monitoring: a fingerprint for cardiovascular disease? Int J Cardiovasc Imaging 2009 0.78
143 IVUS detects more coronary calcifications than MSCT; matter of both resolution and cross-sectional assessment? Int J Cardiovasc Imaging 2010 0.78
144 Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 1998 0.78
145 How many patients with ischemic cardiomyopathy exhibit viable myocardium? Am J Cardiol 2001 0.78
146 Triplane tissue Doppler imaging: a novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy. Heart 2007 0.78
147 Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium. Heart 2006 0.78
148 Triple rule-out CT coronary angiography: three of a kind? Int J Cardiovasc Imaging 2008 0.78
149 Speckle tracking: distinction of physiologic from pathologic LVH? Int J Cardiovasc Imaging 2010 0.78
150 Feasibility of trans-endocardial cell transplantation in chronic ischaemia. Heart 2007 0.78
151 Different imaging approaches in the assessment of left ventricular dysfunction: all things equal? Eur Heart J 2000 0.78
152 Tissue Doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapy. Heart 2009 0.78
153 Tissue Doppler imaging and the quantification of myocardial function. Int J Card Imaging 1998 0.77
154 The grade of worsening of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalities. Heart 2000 0.77
155 Prognosis of transient new-onset atrial fibrillation during vascular surgery. Eur J Vasc Endovasc Surg 2009 0.77
156 Cardiac resynchronization therapy; evaluation by advanced imaging techniques. Int J Cardiovasc Imaging 2009 0.77
157 Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? J Nucl Med 1999 0.77
158 Usefulness of the ejection fraction response to dobutamine infusion in predicting functional recovery after coronary artery bypass grafting in patients with left ventricular dysfunction. Am J Cardiol 2000 0.77
159 Relation among exercise-induced ventricular arrhythmias, myocardial ischemia, and viability late after acute myocardial infarction. Am J Cardiol 2000 0.77
160 Contrast echocardiography as a useful additional diagnostic tool in evaluating a primary cardiac tumor. Eur J Echocardiogr 2005 0.77
161 Beta-blockers improve outcomes in kidney disease patients having noncardiac vascular surgery. Kidney Int 2007 0.77
162 Acquired right ventricular dysfunction. Heart 2006 0.77
163 Effect of coronary artery bypass surgery on myocardial perfusion and ejection fraction response to inotropic stimulation in patients without improvement in resting ejection fraction. Am J Cardiol 2000 0.77
164 [Cardiovascular nuclear medicine 1976/'06: 30 years representation in clinical cardiology]. Ned Tijdschr Geneeskd 2006 0.77
165 Myocardial perfusion imaging: clinical experience and recent progress in radionuclide scintigraphy and magnetic resonance imaging. Int J Card Imaging 1997 0.77
166 Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 1998 0.77
167 Gated myocardial SPECT imaging; true additional value in AMI? Int J Cardiovasc Imaging 2010 0.76
168 Cardiac complications after elective major vascular surgery. Acta Anaesthesiol Scand 2003 0.76
169 Long-term cardiac outcome in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2008 0.76
170 Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium. Heart 2004 0.76
171 Distal protection beneficial? Int J Cardiovasc Imaging 2010 0.76
172 Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization. J Cardiovasc Magn Reson 2010 0.76
173 There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients. J Endocrinol Invest 2004 0.76
174 Gated SPECT in left bundle branch block: from improved diagnosis to improved treatment. Int J Cardiovasc Imaging 2008 0.76
175 Prognosis of vascular surgery patients using a quantitative assessment of troponin T release: is the crystal ball still clear? Eur J Vasc Endovasc Surg 2010 0.76
176 Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol 2001 0.76
177 Echocardiography in Takotsubo cardiomyopathy; a useful approach? Int J Cardiovasc Imaging 2010 0.76
178 Role of dobutamine stress echocardiography for preoperative cardiac risk assessment before major vascular surgery: a diagnostic tool comes of age. Echocardiography 2000 0.76
179 Uncontrolled acromegaly is associated with progressive mitral valvular regurgitation. Growth Horm IGF Res 2006 0.76
180 Positron emission tomography; viable tool in patients pre-CABG? Int J Cardiovasc Imaging 2010 0.76
181 Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 1997 0.76
182 Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2006 0.76
183 Cardiac magnetic resonance imaging analysis in STEMI: quantitative or still visual? Int J Cardiovasc Imaging 2010 0.76
184 CT perfusion angiography; beware of artifacts! Int J Cardiovasc Imaging 2009 0.76
185 Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism. Int J Cardiovasc Imaging 2010 0.76
186 Risk models in abdominal aortic aneurysm surgery; useful for policy makers or patients? Eur J Vasc Endovasc Surg 2007 0.76
187 Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity. J Nucl Cardiol 2000 0.76
188 Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy. Heart 2004 0.76
189 Evaluation of hibernating myocardium. Heart 2004 0.76
190 Clinical and angiographic correlates of dobutamine-induced wall motion patterns after myocardial infarction. Am J Cardiol 2001 0.76
191 Echocardiography and non-invasive imaging in cardiac resynchronization therapy. Minerva Cardioangiol 2010 0.76
192 Short-term overt hypothyroidism induces discrete diastolic dysfunction in patients treated for differentiated thyroid carcinoma. Eur J Clin Invest 2009 0.75
193 Accuracy of dobutamine technetium 99m sestamibi SPECT imaging for the diagnosis of single-vessel coronary artery disease: comparison with echocardiography. Am Heart J 2000 0.75
194 Gated Tc-99m sestamibi SPECT versus stress-rest SPECT in detecting coronary artery disease: correlation with coronary angiography in patients without myocardial infarction. Clin Nucl Med 1999 0.75
195 Asymptomatic low ankle-brachial index in vascular surgery patients: a predictor of perioperative myocardial damage. Eur J Vasc Endovasc Surg 2009 0.75
196 Ischemic heart disease in renal transplant candidates: towards non-invasive approaches for preoperative risk stratification. Eur J Echocardiogr 2005 0.75
197 Cardiac troponins as a risk stratification tool for patients with chronic critical limb ischemia. Eur J Vasc Endovasc Surg 2007 0.75
198 Effect of methodology on mismatch. J Nucl Med 2000 0.75
199 Functional analysis by 64-slice CT scanning: prediction of left ventricular dysfunction together with reduction in radiation exposure? Int J Cardiovasc Imaging 2010 0.75
200 Mitral regurgitation and left ventricular dyssynchrony: implications for treatment. Heart 2006 0.75
201 Prognostic value of viability assessment in chronic ischaemic LV dysfunction. Neth Heart J 2001 0.75
202 Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction. Heart 1997 0.75
203 Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium. Heart 2005 0.75
204 Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography. Heart 2001 0.75
205 Nuclear cardiac imaging for the assessment of myocardial viability. Neth Heart J 2005 0.75
206 Sudden cardiac death and heart failure: can we make a difference? Neth Heart J 2005 0.75
207 Left ventricular mass assessment by CMR; how to define the optimal index. Int J Cardiovasc Imaging 2010 0.75
208 Cardiac applications of multislice computed tomography. Br J Radiol 2006 0.75
209 CT imaging of the heart. Neth Heart J 2006 0.75
210 Non-significant left main disease; truly non-significant? Int J Cardiovasc Imaging 2009 0.75
211 CMR-determined scar volume: predictive for ventricular tachycardias? Int J Cardiovasc Imaging 2011 0.75
212 Cardiac magnetic resonance imaging in primary PCI: additional value? Int J Cardiovasc Imaging 2009 0.75
213 Mitral valve regurgitation: accurate blood flow quantification with MRI. Neth Heart J 2004 0.75
214 Quantification of regional left ventricular function in Q wave and non-Q wave dysfunctional regions by tissue Doppler imaging in patients with ischaemic cardiomyopathy. Heart 2003 0.75
215 Detection of apical hypertrophic cardiomyopathy; which is the appropriate imaging modality. Int J Cardiovasc Imaging 2008 0.75
216 Cardiac risk reduction in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2007 0.75
217 Evidence of scar tissue: contra-indication to cardiac resynchronization therapy? Int J Cardiovasc Imaging 2010 0.75
218 Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned? Int J Cardiovasc Imaging 2008 0.75
219 Noncompaction cardiomyopathy. Neth Heart J 2003 0.75
220 Contrast medium echocardiography-assisted pericardiocentesis of loculated pericardial fluid. Neth Heart J 2002 0.75
221 320-row CT: does beat-to-beat motion of the coronary arteries affect image quality? Int J Cardiovasc Imaging 2011 0.75
222 Cardiovascular molecular MR imaging. Eur J Nucl Med Mol Imaging 2007 0.75
223 Value of attenuation correction for the predictive accuracy of thallium-201 reinjection imaging. Eur J Nucl Med 1999 0.75
224 Changing paradigm: atherosclerosis versus ischaemia. Eur J Nucl Med Mol Imaging 2007 0.75
225 Management of non-Q-wave myocardial infarction. N Engl J Med 1998 0.75
226 Non-invasive assessment of atherosclerotic coronary lesion length using multidetector computed tomography angiography: comparison to quantitative coronary angiography. Int J Cardiovasc Imaging 2012 0.75
227 Increased accuracy in computed tomography coronary angiography; a new body surface area adapted protocol. Int J Cardiovasc Imaging 2010 0.75
228 Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment. Neth Heart J 2003 0.75
229 Re: Secondary medical prevention in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2007 0.75
230 Use of the anterior-posterior chest diameter in CT: reduction in radiation dose? Int J Cardiovasc Imaging 2010 0.75
231 Low-dose CT angiography: sufficient contrast for vessel imaging? Int J Cardiovasc Imaging 2009 0.75
232 Cardiovascular dynamics in ischemic cardiomyopathy during exercise. Int J Cardiovasc Imaging 2010 0.75
233 Dobutamine stress thallium-201 single-photon emission tomography versus echocardiography for evaluation of the extent and location of coronary artery disease late after myocardial infarction. Eur J Nucl Med 1999 0.75
234 Cardiac magnetic resonance imaging; gatekeeper in suspected CAD? Int J Cardiovasc Imaging 2010 0.75
235 CT angiography; useful in non-selected outpatients? Int J Cardiovasc Imaging 2009 0.75
236 Quantification of multi-slice computed tomography coronary angiography: current status and future directions. Acute Card Care 2006 0.75
237 The present of nuclear cardiology: a great past opens the way to a bright future. Q J Nucl Med Mol Imaging 2005 0.75
238 Feasibility of planar fluorine-18-FDG imaging after recent myocardial infarction to assess myocardial viability. J Nucl Med 1995 0.75
239 Relation between exercise-induced ventricular arrhythmias and myocardial perfusion abnormalities in patients with intermediate pretest probability of coronary artery disease. Eur J Nucl Med 2000 0.75
240 Discrimination between pericardial disease and myocardial disease using tissue Doppler imaging in a patient with right-sided heart failure and multiple myeloma. Int J Cardiovasc Imaging 2003 0.75
241 Thrombus in the left atrial appendage detected by intracardiac echocardiography. Int J Cardiovasc Imaging 2004 0.75
242 Stroke volume changes during dobutamine-atropine stress echocardiography: the influence of heart rate and ischaemia. Int J Card Imaging 1999 0.75
243 Echocardiographic studies of dobutamine-induced ST-segment elevation before and after coronary artery bypass grafting in patients with old Q-wave myocardial infarction. J Am Soc Echocardiogr 1999 0.75
244 Heterogeneity of DMIPP uptake and its relationship with heterogeneous myocardial blood flow. J Nucl Med 1997 0.75
245 Abdominal aortic aneurysm screening using non-imaging hand-held ultrasound volume scanner--a pilot study. Eur J Vasc Endovasc Surg 2006 0.75
246 Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans. Nucl Med Commun 1997 0.75
247 [Diagnostic image (296). A woman with a cardiac murmur]. Ned Tijdschr Geneeskd 2006 0.75
248 Prediction of reversibility of wall motion abnormalities after revascularization using F18-fluorodeoxyglucose single photon emission computed tomography. Eur Heart J 1996 0.75
249 Detection of residual wall motion after myocardial infarction by gated technetium-99m tetrofosmin SPET: a comparison with contrast ventriculography. Eur J Nucl Med 2001 0.75
250 [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use]. Ned Tijdschr Geneeskd 2005 0.75
251 Perioperative beta-blockers: is it still useful? Indian Heart J 2010 0.75
252 Impact of heart transplantation on the safety and feasibility of the dobutamine stress test. J Heart Lung Transplant 2001 0.75
253 The prognostic value of dobutamine stress echocardiography in patients with abdominal aortic aneurysm and concomitant coronary artery disease. J Cardiovasc Surg (Torino) 2003 0.75
254 Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography. Eur Heart J 1997 0.75
255 Beta-blockers improve in-hospital and long-term survival in patients with severe left ventricular dysfunction undergoing major vascular surgery. Eur J Vasc Endovasc Surg 2005 0.75
256 Eligibility for biventricular pacing in patients with an implantable cardioverter defibrillator. Eur J Heart Fail 2003 0.75
257 Gender differences in the relation between ST-T-wave abnormalities at baseline electrocardiogram and stress myocardial perfusion abnormalities in patients with suspected coronary artery disease. Am J Cardiol 1999 0.75
258 The short-term effect of intravenous nitroglycerin on haematocrit; an additional benefit in patients with myocardial ischaemia? Eur Heart J 1994 0.75
259 Impaired systolic blood pressure response to dobutamine stress testing: a marker of more severe functional abnormalities in patients with myocardial infarction. J Am Soc Echocardiogr 1998 0.75
260 The future of cardiovascular imaging and non-invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine, and the Association for European Paediatric Cardiology. Eur J Echocardiogr 2006 0.75
261 Course of impaired left ventricular function after acute myocardial infarction predicted with planar thallium-201 chloride and F18-fluorodeoxyglucose imaging. Int J Cardiol 1996 0.75
262 Detection of viability after myocardial infarction: available techniques and clinical relevance--a review. Int J Cardiol 1995 0.75
263 Post-extrasystolic potentiation recruits incremental contractile reserve of dyssynergic myocardium during dobutamine stress testing: evidence by pulsed wave tissue Doppler imaging. Eur J Echocardiogr 2003 0.75
264 Long-term prognostic value of dobutamine stress echocardiography in patients with atrial fibrillation. Chest 2001 0.75
265 Perioperative cardiac risk stratification and modification in abdominal aortic aneurysm repair. Acta Chir Belg 2006 0.75
266 Metabolism of radioiodinated fatty acid analogs in ischemic and hypoxic canine myocardium. J Nucl Med 1999 0.75
267 Myocardial viability: known and unknown. G Ital Cardiol 1998 0.75
268 Myocardial tissue Doppler echocardiography and cardiac resynchronization therapy. Minerva Cardioangiol 2003 0.75
269 Multi-slice computed tomography coronary angiography: anatomic vs functional assessment in clinical practice. Minerva Cardioangiol 2008 0.75
270 ['Migraine and a hole in the heart': causal relationship between migraine and patent foramen ovale not established]. Ned Tijdschr Geneeskd 2006 0.75
271 Cardiogenic shock shortly after initial success of cardiac resynchronization therapy. Eur J Heart Fail 2004 0.75
272 Underestimation of severity of mitral regurgitation with varying hemodynamics. Eur J Echocardiogr 2004 0.75
273 The effect of statins on perioperative events in patients undergoing vascular surgery. Acta Chir Belg 2010 0.75
274 Dobutamine stress-redistribution-reinjection versus rest-redistribution thallium-201 SPECT in the assessment of myocardial viability. Int J Card Imaging 1997 0.75
275 Long term effects of intramyocardial bone marrow cell injection on anginal symptoms and quality of life in patients with chronic myocardial ischemia. Int J Cardiol 2013 0.75
276 The difficulty of adequate risk stratification for patients with asymptomatic diabetes. Circulation 2008 0.75
277 Ventricular tachycardia during dobutamine stress myocardial contrast imaging. Chest 1999 0.75
278 Advanced applications of 3-dimensional echocardiography. Minerva Cardioangiol 2009 0.75